1921
Volume 99, Issue 6
  • ISSN: 0002-9637
  • E-ISSN: 1476-1645

Abstract

Abstract.

In most of India, sulfadoxine–pyrimethamine (SP) artesunate serves as first-line treatment for uncomplicated falciparum malaria. In 112 clinical isolates from Mangaluru, southwestern India, we sequenced molecular markers associated with resistance to SP, lumefantrine, and artemisinin (, , , and ). The double mutation 59R-108N combined with the 437G mutation occurred in 39.3% and the double mutation the double mutation 437G-540E in additional 24.1%. As for , the allele combination N86-184F-D1246 dominated (98.2%). variants were absent. No evidence for artemisinin resistance was seen. However, the antifolate resistance alleles compromise the current first-line antimalarial sulfadoxine–pyrimethamine artesunate, which may facilitate the emergence of artemisinin resistance. Artemether–lumefantrine, introduced in northeastern parts of the country, in the study area faces the predominant NFD genotype, known to impair lumefantrine efficacy. Further monitoring of resistance alleles and treatment trials on alternative artemisinin-based combination therapies are required.

Loading

Article metrics loading...

The graphs shown below represent data from March 2017
/content/journals/10.4269/ajtmh.18-0549
2018-11-05
2019-11-13
Loading full text...

Full text loading...

/deliver/fulltext/14761645/99/6/tpmd180549.html?itemId=/content/journals/10.4269/ajtmh.18-0549&mimeType=html&fmt=ahah

References

  1. Haldar K, Bhattacharjee S, Safeukui I, , 2018. Drug resistance in Plasmodium. Nat Rev Microbiol 16: 156170. [Google Scholar]
  2. Directorate of National Vector Borne Disease Control Programme, Directorate General of Health Services, Ministry of Health and Family Welfare, Government of India, 2013. National Drug Policy on Malaria. Available at: http://nvbdcp.gov.in/Doc/National-Drug-Policy-2013.pdf. Accessed April 24, 2018.
  3. Shah NK, Dhillon GP, Dash AP, Arora U, Meshnick SR, Valecha N, , 2011. Antimalarial drug resistance of Plasmodium falciparum in India: changes over time and space. Lancet Infect Dis 11: 5764. [Google Scholar]
  4. Patel P, Bharti PK, Bansal D, Ali NA, Raman RK, Mohapatra PK, Sehgal R, Mahanta J, Sultan AA, Singh N, , 2017. Prevalence of mutations linked to antimalarial resistance in Plasmodium falciparum from Chhattisgarh, Central India: a malaria elimination point of view. Sci Rep 7: 16690. [Google Scholar]
  5. Pathak A, Mårtensson A, Gawariker S, Mandliya J, Sharma A, Diwan V, Ursing J, , 2014. Characterization of drug resistance associated genetic polymorphisms among Plasmodium falciparum field isolates in Ujjain, Madhya Pradesh, India. Malar J 13: 182. [Google Scholar]
  6. Mohapatra PK, Sarma DK, Prakash A, Bora K, Ahmed MA, Sarma B, Goswami BK, Bhattacharyya DR, Mahanta J, , 2014. Molecular evidence of increased resistance to anti-folate drugs in Plasmodium falciparum in north-east India: a signal for potential failure of artemisinin plus sulphadoxine-pyrimethamine combination therapy. PLoS One 9: e105562. [Google Scholar]
  7. Mishra N, 2014. Declining efficacy of artesunate plus sulphadoxine-pyrimethamine in northeastern India. Malar J 13: 284. [Google Scholar]
  8. Sharma J, Khan SA, Dutta P, Mahanta J, , 2015. Molecular determination of antifolate resistance associated point mutations in Plasmodium falciparum dihydrofolate reductase (dhfr) and dihydropteroate synthetase (dhps) genes among the field samples in Arunachal Pradesh. J Vector Borne Dis 52: 116121. [Google Scholar]
  9. Gregson A, Plowe CV, , 2005. Mechanisms of resistance of malaria parasites to antifolates. Pharmacol Rev 57: 117145. [Google Scholar]
  10. Mita T, Ohashi J, Venkatesan M, Marma AS, Nakamura M, Plowe CV, Tanabe K, , 2014. Ordered accumulation of mutations conferring resistance to sulfadoxine-pyrimethamine in the Plasmodium falciparum parasite. J Infect Dis 209: 130139. [Google Scholar]
  11. Blasco B, Leroy D, Fidock DA, , 2017. Antimalarial drug resistance: linking Plasmodium falciparum parasite biology to the clinic. Nat Med 23: 917928. [Google Scholar]
  12. Mishra N, Bharti RS, Mallick P, Singh OP, Srivastava B, Rana R, Phookan S, Gupta HP, Ringwald P, Valecha N, , 2016. Emerging polymorphisms in falciparum Kelch 13 gene in northeastern region of India. Malar J 15: 583. [Google Scholar]
  13. Gai PP, 2018. Manifestation of malaria in Mangaluru, southern India. Malar J 17: 313. [Google Scholar]
  14. Snounou G, Viriyakosol S, Jarra W, Thaithong S, Brown KN, , 1993. Identification of the four human malaria parasite species in field samples by the polymerase chain reaction and detection of a high prevalence of mixed infections. Mol Biochem Parasitol 58:283292. [Google Scholar]
  15. Kublin JG, 2002. Molecular markers for failure of sulfadoxine-pyrimethamine and chlorproguanil-dapsone treatment of Plasmodium falciparum malaria. J Infect Dis 185: 380388. [Google Scholar]
  16. Nagesha HS, Din-Syafruddin Casey GJ, Susanti AI, Fryauff DJ, Reeder JC, Cowman AF, , 2001. Mutations in the pfmdr1, dhfr and dhps genes of Plasmodium falciparum are associated with in-vivo drug resistance in West Papua, Indonesia. Trans R Soc Trop Med Hyg 95: 4349. [Google Scholar]
  17. Veiga MI, Dhingra SK, Henrich PP, Straimer J, Gnädig N, Uhlemann AC, Martin RE, Lehane AM, Fidock DA, , 2016. Globally prevalent PfMDR1 mutations modulate Plasmodium falciparum susceptibility to artemisinin-based combination therapies. Nat Commun 7: 11553. [Google Scholar]
  18. Venkatesan M, 2014. Polymorphisms in Plasmodium falciparum chloroquine resistance transporter and multidrug resistance 1 genes: parasite risk factors that affect treatment outcomes for P. falciparum malaria after artemether-lumefantrine and artesunate-amodiaquine. Am J Trop Med Hyg 91: 833843. [Google Scholar]
  19. Malmberg M, Ferreira PE, Tarning J, Ursing J, Ngasala B, Björkman A, Mårtensson A, Gil JP, , 2013. Plasmodium falciparum drug resistance phenotype as assessed by patient antimalarial drug levels and its association with pfmdr1 polymorphisms. J Infect Dis 207: 842847. [Google Scholar]
http://instance.metastore.ingenta.com/content/journals/10.4269/ajtmh.18-0549
Loading
/content/journals/10.4269/ajtmh.18-0549
Loading

Data & Media loading...

  • Received : 06 Jul 2018
  • Accepted : 14 Sep 2018
  • Published online : 05 Nov 2018

Most Cited This Month

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error